The safety profile of favipiravir in COVID-19 patients with severe renal impairment.

Selim Gök Ömer Faruk Bahçecioğlu Mefküre Durmuş Zeynep Ülkü Gün Yasemin Ersoy Zeynep Ayfer Aytemur Özkan Ulutaş

Published in: International journal of clinical practice (2021)

Even though favipiravir appeared to be well tolerated in the individuals with renal failure in this study, its use in this population remains a challenge that requires more research and analysis.

Keyphrases

coronavirus disease
sars cov
early onset
respiratory syndrome coronavirus